This statistic depicts the average number of days a patient will stay in the hospital for an hematopoietic stem cell (HSC) transplant in the United States as of 2014, by procedure type. According to the data, in 2014, a cord blood stem cell transplant required an average of 51.2 days in the hospital.
Average length of stay for an inpatient hematopoietic stem cell (HSC) transplant in the United States in 2014, by procedure
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Cell and gene therapy
Market overview
6
- Basic Statistic Global market size for regenerative medicine 2021-2030
- Premium Statistic Global cell and gene therapy manufacturing market forecast 2023-2033
- Basic Statistic Global cell culture market size 2022-2030
- Premium Statistic ATMP classification share worldwide 2016
- Basic Statistic Regenerative medicine companies by world region 2023
- Basic Statistic Market cap of gene and cell therapy companies 2023
R&D/trials
5
- Premium Statistic ATMP trials classification share by disease and development phase globally 2016
- Premium Statistic ATMP clinical trials share globally by type of sponsor
- Premium Statistic ATMP clinical trials non-commercial sponsors distribution globally 2016
- Premium Statistic Number of biotech therapies in development as of 2017, by developer
- Basic Statistic Percentage of biotech therapies in development as of 2017, by developer
Stem cells
5
- Premium Statistic Global stem cell market size by world region 2011-2016
- Premium Statistic Stem cell technologies and applications market share by world region 2016
- Premium Statistic Global stem cell market size forecast 2022-2030
- Premium Statistic Number of HSC transplants in the US from 2010-2015, by source
- Premium Statistic Total stem cell research funding by the National Institutes for Health 2013-2024
Cord blood
5
- Basic Statistic Aggregate annual demand for cord blood units from 2010-2016
- Premium Statistic Annual social value of U.S. CBB system by scenario 2010-2016
- Premium Statistic Percentage of CBUs from the U.S. shipped domestically and internationally 2010-2016
- Basic Statistic Percentage of shipped U.S. cord blood units by TNC count 2002-2016
- Premium Statistic Percentage of stored U.S. CBUs by TNC count 2002-2016
CAR/CAR-T
4
Miscellaneous
5
- Basic Statistic Length of hospital stay for an HSC transplant in the U.S. in 2014, by procedure
- Premium Statistic Medicaid charges and costs for an HSC transplant in the U.S. in 2014, by procedure
- Premium Statistic Capital raised by regenerative medicine companies worldwide 2016-2022
- Basic Statistic Select market-stage ATMPs price in the U.S. as of 2016
- Premium Statistic View of increasing government funding for stem cell research - U.S. adults 2017
Further related statistics
18
- Hospital costs for an HSC transplant in the U.S. in 2014, by procedure
- Medicare charges and costs for an HSC transplant in 2014, by procedure
- Number of HSC transplants in the US from 2010-2016, by condition and source
- Number of HSC transplants in the US from 2010-2016, by condition
- Number of HSC transplants in the US from 2010-2015
- U.S. population with delayed or not received medical care due to cost 2001-2022
- Medical conditions U.S. adults have been treated for in hospitals 2017, by community
- Adults with inpatient and outpatient hospital treatments in preceding 5 years 2017
- Medical conditions U.S. adults have been treated for in hospitals 2017, by ethnicity
- Leading medical conditions U.S. adults have been treated for in hospitals 2017
- Stem cell assay market value in Latin America 2022-2027
- Level of satisfaction with hospital treatments among U.S. adults 2017
- Level of satisfaction with hospital treatments among U.S. adults 2017, by community
- Americans' moral stance towards using stem cells obtained from human embryos in 2018
- Adults with outpatient hospital treatments in preceding 5 years 2017, by gender
- Number of females with chronic pain Australia 2018-2050
- Prevalence of chronic pain among males by age group Australia 2018
- Italy: number of cochlear implantations performed 2010-2015
Further Content: You might find this interesting as well
Statistics
- Hospital costs for an HSC transplant in the U.S. in 2014, by procedure
- Medicare charges and costs for an HSC transplant in 2014, by procedure
- Number of HSC transplants in the US from 2010-2016, by condition and source
- Number of HSC transplants in the US from 2010-2016, by condition
- Number of HSC transplants in the US from 2010-2015
- U.S. population with delayed or not received medical care due to cost 2001-2022
- Medical conditions U.S. adults have been treated for in hospitals 2017, by community
- Adults with inpatient and outpatient hospital treatments in preceding 5 years 2017
- Medical conditions U.S. adults have been treated for in hospitals 2017, by ethnicity
- Leading medical conditions U.S. adults have been treated for in hospitals 2017
- Stem cell assay market value in Latin America 2022-2027
- Level of satisfaction with hospital treatments among U.S. adults 2017
- Level of satisfaction with hospital treatments among U.S. adults 2017, by community
- Americans' moral stance towards using stem cells obtained from human embryos in 2018
- Adults with outpatient hospital treatments in preceding 5 years 2017, by gender
- Number of females with chronic pain Australia 2018-2050
- Prevalence of chronic pain among males by age group Australia 2018
- Italy: number of cochlear implantations performed 2010-2015
RAND Corporation. (September 29, 2017). Average length of stay for an inpatient hematopoietic stem cell (HSC) transplant in the United States in 2014, by procedure [Graph]. In Statista. Retrieved April 25, 2024, from https://www.statista.com/statistics/799910/hospital-length-of-stay-for-us-hsc-transplants-by-procedure/
RAND Corporation. "Average length of stay for an inpatient hematopoietic stem cell (HSC) transplant in the United States in 2014, by procedure." Chart. September 29, 2017. Statista. Accessed April 25, 2024. https://www.statista.com/statistics/799910/hospital-length-of-stay-for-us-hsc-transplants-by-procedure/
RAND Corporation. (2017). Average length of stay for an inpatient hematopoietic stem cell (HSC) transplant in the United States in 2014, by procedure. Statista. Statista Inc.. Accessed: April 25, 2024. https://www.statista.com/statistics/799910/hospital-length-of-stay-for-us-hsc-transplants-by-procedure/
RAND Corporation. "Average Length of Stay for An Inpatient Hematopoietic Stem Cell (Hsc) Transplant in The United States in 2014, by Procedure." Statista, Statista Inc., 29 Sep 2017, https://www.statista.com/statistics/799910/hospital-length-of-stay-for-us-hsc-transplants-by-procedure/
RAND Corporation, Average length of stay for an inpatient hematopoietic stem cell (HSC) transplant in the United States in 2014, by procedure Statista, https://www.statista.com/statistics/799910/hospital-length-of-stay-for-us-hsc-transplants-by-procedure/ (last visited April 25, 2024)
Average length of stay for an inpatient hematopoietic stem cell (HSC) transplant in the United States in 2014, by procedure [Graph], RAND Corporation, September 29, 2017. [Online]. Available: https://www.statista.com/statistics/799910/hospital-length-of-stay-for-us-hsc-transplants-by-procedure/